“Predominantly present amongst the males the development of the prostate cancer takes place in the male reproductive system. The cells permutate and then slowly multiply and spread throughout the entire body sometimes even to the bones. It is an afflictive disease that is mostly common amongst the older age group of men residing in UK, US and Asia. Amongst other causes the primary factor is the genetics and the diet routine. The disease does not show itself until it has progressed to a later stage so there are possibly no initial symptoms that can help in its identification. The most common way of its detection is its display during ongoing routine checkups. Only rare cases may show some vague symptoms that might involve the infrequent urination patterns throughout the day and especially during sleeping hours. Only after commencement to an advance level do the full symptoms become evident.

After diagnosis the prostate cancer demands a comprehensive treatment plan for the achievement of a possible remedy against this ailment. First of all nomograms are conducted for the prediction of the extension of disease throughout the body. Some of the common treatments for this malady involves keeping a regular comprehensive check, surgery, radiation therapy or in many eventualities a chemotherapy. But before the inception of a particular treatment plan several factors have to be taken into consideration namely the patients age, health and his feelings regarding the prospective treatment plans and their considerable side effects, which may range from the erectile dysfunction to urinary incontinence.”

Xeloda, a product of Roche Pharmaceuticals in the United State has been on the market since 1998 when it was the first oral chemotherapy approved by the FDA for the treatment of metastatic Breast Cancer. Xeloda is being studied as a potential treatment for other types of cancer. But right now it is approved only for the treatment of metastatic Breast and Colorectal Cancers and Dukes’ C (Stage III) Colon Cancer.

Xeloda helps people with breast cancer to prevent the spread and improvement of metastatic cells to another parts of the body. People taking Xeloda will be provided full knowledge about their disease and advices from Oncology nurses (who is trained to provide information about your XELODA therapy and keeps in contact with your doctor to stay on top of your current treatment plan) throughout the treatment so they are sure to get high effective and time-saving.

Nowadays, Xeloda is more and more widespread with presenting in more than 60 countries all over the world.